Compare FATE & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FATE | ILLR |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.5M | 122.5M |
| IPO Year | 2013 | N/A |
| Metric | FATE | ILLR |
|---|---|---|
| Price | $1.08 | $0.55 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.92 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 369.1K |
| Earning Date | 11-13-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,137,000.00 | ★ $45,244,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.33 |
| 52 Week High | $2.93 | $4.06 |
| Indicator | FATE | ILLR |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 53.92 |
| Support Level | $0.99 | $0.37 |
| Resistance Level | $1.16 | $0.58 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 61.54 | 88.00 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.